Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.

Autor: Barbosa TC; Division of Clinical Research and Technological Development, Research Center, Instituto Nacional de Câncer (INCA), 37. Post code: 20231050, Rio de Janeiro, RJ, Brazil., Oliveira E; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Blunck CB; Division of Clinical Research and Technological Development, Research Center, Instituto Nacional de Câncer (INCA), 37. Post code: 20231050, Rio de Janeiro, RJ, Brazil., Maciel A; Division of Clinical Research and Technological Development, Research Center, Instituto Nacional de Câncer (INCA), 37. Post code: 20231050, Rio de Janeiro, RJ, Brazil., Bastos A; Division of Clinical Research and Technological Development, Research Center, Instituto Nacional de Câncer (INCA), 37. Post code: 20231050, Rio de Janeiro, RJ, Brazil., Bouzada H; Division of Clinical Research and Technological Development, Research Center, Instituto Nacional de Câncer (INCA), 37. Post code: 20231050, Rio de Janeiro, RJ, Brazil., Rouxinol ST; Pediatric Hematology Department, Hospital Federal da Lagoa (HFL), Rio de Janeiro, RJ, Brazil., Mansur MB; Division of Clinical Research and Technological Development, Research Center, Instituto Nacional de Câncer (INCA), 37. Post code: 20231050, Rio de Janeiro, RJ, Brazil; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital and MRC Weatherall Institute of Molecular Medicine - WIMM, University of Oxford, Oxford, UK., Costa ES; Cytometry Service, Instituto de Puericultura e Pediatria Martagão Gesteira, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Almeida CW; Pediatric Hematology Department, Hospital Federal da Lagoa (HFL), Rio de Janeiro, RJ, Brazil., Emerenciano M; Division of Clinical Research and Technological Development, Research Center, Instituto Nacional de Câncer (INCA), 37. Post code: 20231050, Rio de Janeiro, RJ, Brazil. Electronic address: memerenciano@inca.gov.br.
Jazyk: angličtina
Zdroj: Cancer genetics [Cancer Genet] 2023 Aug; Vol. 276-277, pp. 40-42. Date of Electronic Publication: 2023 Jul 16.
DOI: 10.1016/j.cancergen.2023.07.002
Abstrakt: Competing Interests: Declaration of Competing Interest The authors have no conflicts of interest to report.
Databáze: MEDLINE
Externí odkaz: